{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:39:38Z","timestamp":1781649578465,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T00:00:00Z","timestamp":1202342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00520-007-0401-1","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T10:53:55Z","timestamp":1202295235000},"page":"757-761","source":"Crossref","is-referenced-by-count":6,"title":["Lifting symptom burden\u2014how far off the ground are we?"],"prefix":"10.1007","volume":"16","author":[{"given":"Mellar P.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordanka","family":"Kirkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,7]]},"reference":[{"issue":"1","key":"401_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SC Teunissen","year":"2007","unstructured":"Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34(1):94\u2013104. Jul","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"401_CR2","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/cncr.11815","volume":"98","author":"NI Cherny","year":"2003","unstructured":"Cherny NI, Catane R, European Society of Medical Oncology Taskforce on Palliative and Supportive Care (2003) Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survey by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care. Cancer 98(11):2502\u20132510. Dec 1","journal-title":"Cancer"},{"issue":"9 Suppl 10","key":"401_CR3","first-page":"64","volume":"16","author":"CS Cleeland","year":"2002","unstructured":"Cleeland CS, Reyes-Gibby CC (2002) When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston Park) 16(9 Suppl 10):64\u201370. Sep","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"401_CR4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.hoc.2005.02.007","volume":"19","author":"M Boyar","year":"2005","unstructured":"Boyar M, Raftopoulos H (2005) Supportive care in lung cancer. Hematol Oncol Clin North Am 19(2):369\u2013387. vii, Apr","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"401_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.coc.0000258732.80710.05","volume":"30","author":"R Bukowski","year":"2007","unstructured":"Bukowski R, Cella D, Gondek K, Escudier B, Sorafenib TARGETs Clinical Trial Group (2007) Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer. Am J Clin Oncol 30(3):220\u2013227. Jun","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"401_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:QURE.0000015297.91158.01","volume":"13","author":"J Bacik","year":"2004","unstructured":"Bacik J, Mazumdar M, Murphy BA, Fairclough DL, Eremenco S, Mariani T et al (2004) The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers. Qual Life Res 13(1):137\u2013154. Feb","journal-title":"Qual Life Res"},{"issue":"5","key":"401_CR7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0885-3924(99)00008-1","volume":"17","author":"C Miaskowski","year":"1999","unstructured":"Miaskowski C, Lee KA (1999) Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 17(5):320\u2013332. May","journal-title":"J Pain Symptom Manage"},{"key":"401_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","volume":"37","author":"CS Cleeland","year":"2007","unstructured":"Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16\u201321. 2(37):16\u201321","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"9","key":"401_CR9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00520-007-0259-2","volume":"15","author":"J Kirkova","year":"2007","unstructured":"Kirkova J, Walsh D (2007) (Sep) Cancer symptom clusters\u2014a dynamic construct. Support Care Cancer 15(9):1011\u20131013","journal-title":"Support Care Cancer"},{"issue":"3","key":"401_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1188\/07.ONF.673-680","volume":"34","author":"RL Gapstur","year":"2007","unstructured":"Gapstur RL (2007) Symptom burden: a concept analysis and implications for oncology nurses. Oncol Nurs Forum 34(3):673\u2013680. May","journal-title":"Oncol Nurs Forum"},{"issue":"5","key":"401_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000079408","volume":"11","author":"BN Lee","year":"2004","unstructured":"Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM, Dunn AJ et al (2004) A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11(5):279\u2013292","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"401_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0959-8049(01)00332-X","volume":"38","author":"P Servaes","year":"2002","unstructured":"Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38(1):27\u201343. Jan","journal-title":"Eur J Cancer"},{"issue":"1","key":"401_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0885-3924(00)00148-2","volume":"20","author":"MR Visser","year":"2000","unstructured":"Visser MR, Smets EM, Sprangers MA, de Haes HJ (2000) How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage 20(1):12\u201318. Jul","journal-title":"J Pain Symptom Manage"},{"issue":"32","key":"401_CR14","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1200\/JCO.2007.11.3845","volume":"25","author":"K Gondek","year":"2007","unstructured":"Gondek K, Sagnier PP, Gilchrist K, Woolley JM (2007) Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels. J Clin Oncol 25(32):5087\u20135093. Nov 10","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"401_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.12-S1-43","volume":"12","author":"JK Carroll","year":"2007","unstructured":"Carroll JK, Kohli S, Mustian KM, Roscoe JA, Morrow GR (2007) Pharmacologic treatment of cancer-related fatigue. Oncologist 12(Suppl 1):43\u201351","journal-title":"Oncologist"},{"issue":"9 Suppl 10","key":"401_CR16","first-page":"117","volume":"16","author":"JD Kallich","year":"2002","unstructured":"Kallich JD, Tchekmedyian NS, Damiano AM, Shi J, Black JT, Erder MH (2002) Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology (Williston Park) 16(9 Suppl 10):117\u2013124. Sep","journal-title":"Oncology (Williston Park)"},{"issue":"7","key":"401_CR17","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/cncr.22943","volume":"110","author":"JL Gabrilove","year":"2007","unstructured":"Gabrilove JL, Perez EA, Tomita DK, Rossi G, Cleeland CS (2007) Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200\u00a0\u03bcg every 2\u00a0weeks. Cancer 110(7):1629\u20131640. Oct 1","journal-title":"Cancer"},{"key":"401_CR18","unstructured":"US Department of Health and Human Services. Patient-reported outcomes measures\u2014use in medical product development to support labeling claims. 2006; Available at: http:\/\/www.fda.gov\/cder\/guidance\/5460dft.pdf ."},{"issue":"7","key":"401_CR19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ejca.2004.01.014","volume":"40","author":"F Efficace","year":"2004","unstructured":"Efficace F, Biganzoli L, Piccart M, Coens C, Van Steen K, Cufer T et al (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40(7):1021\u20131030. May","journal-title":"Eur J Cancer"},{"issue":"5","key":"401_CR20","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2003.09.100","volume":"58","author":"FM Fang","year":"2004","unstructured":"Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY (2004) Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 58(5):1394\u20131404. Apr 1","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"401_CR21","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2005.10.522","volume":"23","author":"BJ Monk","year":"2005","unstructured":"Monk BJ, Huang HQ, Cella D, Long HJ 3rd, Gynecologic Oncology Group Study (2005) Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 23(21):4617\u20134625. Jul 20","journal-title":"J Clin Oncol"},{"issue":"6","key":"401_CR22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403\u20132413. Jun","journal-title":"J Clin Oncol"},{"issue":"3","key":"401_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0360-3016(85)90195-6","volume":"11","author":"MB Parliament","year":"1985","unstructured":"Parliament MB, Danjoux CE, Clayton T (1985) Is cancer treatment toxicity accurately reported. Int J Radiat Oncol Biol Phys 11(3):603\u2013608. Mar","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"401_CR24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/jnci\/94.16.1184","volume":"94","author":"CG Varricchio","year":"2002","unstructured":"Varricchio CG, Sloan JA (2002) The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer. J Natl Cancer Inst 94(16):1184\u20131185. Aug 21","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"401_CR25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/cncr.22444","volume":"109","author":"MM Huschka","year":"2007","unstructured":"Huschka MM, Mandrekar SJ, Schaefer PL, Jett JR, Sloan JA (2007) A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer 109(4):787\u2013795. Feb 15","journal-title":"Cancer"},{"issue":"10","key":"401_CR26","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1200\/JCO.2005.07.167","volume":"23","author":"B Movsas","year":"2005","unstructured":"Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R et al (2005) Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 23(10):2145\u20132154. Apr 1","journal-title":"J Clin Oncol"},{"issue":"34","key":"401_CR27","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1200\/JCO.2007.11.2243","volume":"25","author":"E Basch","year":"2007","unstructured":"Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D et al (2007) Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 25(34):5374\u20135380. Dec 1","journal-title":"J Clin Oncol"},{"issue":"5","key":"401_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1525-1438.2002.t01-1-01147.x","volume":"12","author":"EA Barnes","year":"2002","unstructured":"Barnes EA, Bruera E (2002) Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 12(5):424\u2013428. Sep\u2013Oct","journal-title":"Int J Gynecol Cancer"},{"issue":"32","key":"401_CR29","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1200\/JCO.2007.12.7670","volume":"25","author":"JA Sloan","year":"2007","unstructured":"Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt G et al (2007) Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin.Oncol 25(32):5070\u20135077. Nov 10","journal-title":"J Clin.Oncol"},{"issue":"8","key":"401_CR30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","volume":"118","author":"GH Guyatt","year":"1993","unstructured":"Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118(8):622\u2013629. Apr 15","journal-title":"Ann Intern Med"},{"issue":"5","key":"401_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1025014509626","volume":"12","author":"JS Lai","year":"2003","unstructured":"Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW (2003) Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res 12(5):485\u2013501. Aug","journal-title":"Qual Life Res"},{"issue":"2","key":"401_CR32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0163278705275340","volume":"28","author":"KJ Yost","year":"2005","unstructured":"Yost KJ, Eton DT (2005) Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof 28(2):172\u2013191. Jun","journal-title":"Eval Health Prof"},{"issue":"6","key":"401_CR33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpainsymman.2006.09.024","volume":"33","author":"M Dahele","year":"2007","unstructured":"Dahele M, Skipworth RJ, Wall L, Voss A, Preston T, Fearon KC (2007) Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain Symptom Manage 33(6):676\u2013685. Jun","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"401_CR34","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.2004.10.020","volume":"23","author":"TE Witzig","year":"2005","unstructured":"Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA et al (2005) Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 23(12):2606\u20132617. Apr 20","journal-title":"J Clin Oncol"},{"issue":"11","key":"401_CR35","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0959-8049(99)00192-6","volume":"35","author":"D Osoba","year":"1999","unstructured":"Osoba D (1999) What has been learned from measuring health-related quality of life in clinical oncology? Eur J Cancer 35(11):1565\u20131570. Oct","journal-title":"Eur J Cancer"},{"issue":"4","key":"401_CR36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1586\/14737140.6.4.531","volume":"6","author":"CA Dooms","year":"2006","unstructured":"Dooms CA, Pat KE, Vansteenkiste JF (2006) The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer. Expert Rev Anticancer Ther 6(4):531\u2013544. Apr","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"401_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03256226","volume":"11","author":"S Marsh","year":"2007","unstructured":"Marsh S (2007) Impact of pharmacogenomics on clinical practice in oncology. Mol Diagn Ther 11(2):79\u201382","journal-title":"Mol Diagn Ther"},{"key":"401_CR38","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2741\/2815","volume":"13","author":"S Chada","year":"2008","unstructured":"Chada S, Menander KB, Bocangel D, Roth JA, Ramesh R (2008) Cancer targeting using tumor suppressor genes. Front Biosci 13:1959\u20131967. Jan 1","journal-title":"Front Biosci"},{"issue":"3","key":"401_CR39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2004.11.018","volume":"48","author":"LJ Fallowfield","year":"2005","unstructured":"Fallowfield LJ, Harper P (2005) Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer. Lung Cancer 48(3):365\u2013377. Jun","journal-title":"Lung Cancer"},{"issue":"7161","key":"401_CR40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bmj.317.7161.771","volume":"317","author":"G Silvestri","year":"1998","unstructured":"Silvestri G, Pritchard R, Welch HG (1998) Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 317(7161):771\u2013775. Sep 19","journal-title":"BMJ"},{"issue":"1","key":"401_CR41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gtc.2005.12.010","volume":"35","author":"I Hassan","year":"2006","unstructured":"Hassan I, Cima RC, Sloan JA (2006) Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies. Gastroenterol.Clin.North Am 35(1):53\u201364. Mar","journal-title":"Gastroenterol.Clin.North Am"},{"issue":"8","key":"401_CR42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(05)70284-9","volume":"6","author":"R Kaiser","year":"2005","unstructured":"Kaiser R (2005) Antiemetic guidelines: are they being used? Lancet Oncol 6(8):622\u2013625. Aug","journal-title":"Lancet Oncol"},{"issue":"5","key":"401_CR43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/104990910302000508","volume":"20","author":"KA Nelson","year":"2003","unstructured":"Nelson KA, Walsh D (2003) The business of palliative medicine\u2014Part 3: The development of a palliative medicine program in an academic medical center. Am J Hosp Palliat Care 20(5):345\u2013352. Sep\u2013Oct","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"401_CR44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jpainsymman.2003.10.011","volume":"27","author":"F Strasser","year":"2004","unstructured":"Strasser F, Sweeney C, Willey J, Benisch-Tolley S, Palmer JL, Bruera E (2004) Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage. 27(6):481\u2013491. Jun","journal-title":"J Pain Symptom Manage."},{"issue":"4","key":"401_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00520-002-0341-8","volume":"10","author":"J Homsi","year":"2002","unstructured":"Homsi J, Walsh D, Nelson KA, LeGrand SB, Davis M, Khawam E et al (2002) The impact of a palliative medicine consultation service in medical oncology. Support. Care Cancer 10(4):337\u2013342. May","journal-title":"Support. Care Cancer"},{"issue":"5","key":"401_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/104990910402100511","volume":"21","author":"D Walsh","year":"2004","unstructured":"Walsh D, Zhukovsky DS (2004) Communication in palliative medicine: a pilot study of a problem list to capture complex medical information. Am J Hosp Palliat Care 21(5):365\u2013371. Sep\u2013Oct.","journal-title":"Am J Hosp Palliat Care"},{"issue":"7","key":"401_CR47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00019053-200725070-00002","volume":"25","author":"FG Jansman","year":"2007","unstructured":"Jansman FG, Postma MJ, Brouwers JR (2007) Cost considerations in the treatment of colorectal cancer. Pharmacoeconomics 25(7):537\u2013562","journal-title":"Pharmacoeconomics"},{"issue":"32","key":"401_CR48","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1200\/JCO.2007.12.2341","volume":"25","author":"SF Garcia","year":"2007","unstructured":"Garcia SF, Cella D, Clauser SB, Flynn KE, Lai JS, Reeve BB et al (2007) Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25(32):5106\u20135112. Nov 10","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-007-0401-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0401-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:46Z","timestamp":1559095306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-007-0401-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1007\/s00520-007-0401-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,7]]}}}